•  
  •  
 

Abstract

Introduction. Based on its effectiveness, a percutaneous breast biopsy was chosen because it has minimum side effects and fewer complications, does not distort the breast tissue architecture, and can be performed on an outpatient basis. However, the biopsy can damage the integrity of tumor cells, creating seeding at the site of the track made. Therefore, core biopsy is the method of choice for breast lesion sampling using a 14G needle that provides greater sensitivity. This study aims to explain whether the percutaneous biopsy track has the potential for the formation of tumor cell seeding and its clinical impact.

Methods. Literature searches were conducted in online databases, including Cochrane Library, MEDLINE (PubMed), ScienceDirect, CINAHL (EBSCOhost), and Google Scholar.

Results. Eight articles were selected after a literature search and review.

Conclusion. The potential of tumor seeding formation in the percutaneous breast biopsy tracks varies statistically in number. Overall, the potential of tumor seeding in the percutaneous breast biopsy tracks varies, and the clinical impact is insignificant. Variations in the prevalence of tumor seeding still inconclusive the potential for tumor seeding formation in the percutaneous breast biopsy pathway, particularly core biopsy. Tumor seeding is only found microscopically and does not have a significant clinical impact.

Included in

Surgery Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.